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In the title compound, C11H11NO4S H2O, the ﬁve-membered
thiazolidine ring is nearly planar, with a maximum deviation of
0.010 (2) A ˚ . The dihedral angle between the thiazolidine and
benzene rings is 49.16 (9) . Intermolecular O—H   O and
N—H   O hydrogen bonding is present in the crystal
structure.
Related literature
For the therapeutic and pharmacological properties of thia-
zolidinediones, see: Day (1999); Spiegelman (1998). For the
synthesis of the title compound, see: Madhavan et al. (2002);
Shoda et al. (1983). For related structures, see: Divjakovic ´ et al.






a = 10.684 (4) A ˚
b = 8.151 (3) A ˚
c = 14.747 (5) A ˚
  = 99.657 (4) 
V = 1266.0 (8) A ˚ 3
Z =4
Mo K  radiation
  = 0.27 mm
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T = 293 K
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Data collection




Tmin = 0.960, Tmax = 0.974
4985 measured reﬂections
2226 independent reﬂections











H atoms treated by a mixture of
independent and constrained
reﬁnement
 max = 0.22 e A ˚  3
 min =  0.31 e A ˚  3
Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N3—H3   O2
i 0.86 2.03 2.886 (2) 174
O4—H4A   O5
ii 0.82 1.87 2.685 (2) 171
O5—H5A   O3 0.82 (5) 2.19 (5) 2.962 (2) 156 (4)
O5—H5A   O4 0.82 (5) 2.37 (4) 2.947 (2) 127 (4)
O5—H5B   O1
iii 0.85 (3) 1.97 (3) 2.795 (3) 163 (3)
Symmetry codes: (i)  x þ 1; y þ 2; z þ 2; (ii)  x þ 1
2;y þ 1
2; z þ 1
2; (iii)
 x þ 1; y þ 2; z þ 1.
Data collection: SMART (Bruker, 2003); cell reﬁnement: SAINT
(Bruker, 2003); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to reﬁne
structure: SHELXTL; molecular graphics: SHELXTL; software used
to prepare material for publication: SHELXTL.
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Supplementary data and ﬁgures for this paper are available from the
IUCr electronic archives (Reference: XU5102).
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5-(4-Hydroxy-3-methoxybenzyl)-1,3-thiazolidine-2,4-dione monohydrate
L.-Y. Xiong, T.-F. Wang, L.-P. Zheng, C. Zhang and F.-C. Wang
Comment
Thiazolidinediones (TZDs), which are known to sensitize tissues to insulin, have been developed and clinically used as
antidiabetic agents. They have been shown to reduce plasma glucose, lipid, and insulin levels, and used for the treatment of
type 2 diabetes (Day, 1999; Spiegelman, 1998). Prompted by the activity of TZDs, we have synthesized the title compound
to study its crystal structure.
The asymmetric unit contains a 5-(4-hydroxy-3-methoxybenzyl)thiazolidine-2,4-dione molecule and a solvate water
molecule (Fig. 1). The geometric parameter of the title compoundare to its related structures (Divjakovic et al., 1991;
Yathirajan et al., 2005). The dihedral angle between the thiazolidinedione ring [S1/C2/N3/C4/C5] and the benzene ring
[C7–C12] is 49.16 (9)°. In the crystal packing (Fig. 2), the molecules are linked via intermolecular N1—H1···O2 hydrogen
bonds. In addition, the molecule is connected to the water molecule by O5—H5···O1, O5—H5···O4, O5—H5···O3 and
O4—H4···O5 hydrogen bonds which generate a three dimensional network (Table 1).
Experimental
A mixture of 2,4-tThiazolidinedione (3.51 g, 0.03 mol), 4-hydroxy-3-methoxybenzaldehyde (4.56 g, 0.03 mol), acetic acid
(0.18 g, 0.003 mol) and piperidine (0.26 g, 0.003 mol) in toluene (60 ml) was refluxed for 5 h with continuous removal of
water. The reaction mixture was cooled to room temperature and the resultant crystalline compound was filtered and washed
with water and dried to afford the (Z)-5-(4-hydroxy-3-methoxybenzylidene)thiazolidine-2,4-dione. Yield=7.33 g, 97.3%.
To a solution of (Z)-5-(4-hydroxy-3-methoxybenzylidene) thiazolidine-2,4-dione (4 g, 0.016 mol) in 1,4-dioxane (400 ml),
hydrogenated in the presence of 10% Pd/C (1.0 g) at 60 psi for 24 h. The mixture was filtered through a bed of Celite. The
filtrate was evaporated under reduced pressure and purified by column chromatography using 50:1 CH2Cl2/MeOH to afford
the title compound as yellowish solid. Yield = 1.96 g, 48.6% (Madhavan et al., 2002; Shoda et al., 1983). Crystallization
of the product was carried out by dissolving the product in 10 ml a solvent mixture of MeOH and water (4:1) at room
temperature.
Refinement
Water H atoms were located in a difference Fourier map and refined isotropically. Other H atoms were positioned geomet-
rically and refined using the riding-model approximation with C—H = 0.93–0.97, O—H = 0.82 and N—H = 0.86 Å, and
Uiso(H) = 1.5Ueq(C,O) for methyl H and hydroxy H atoms and 1.2Ueq(C,N) for the others.supplementary materials
sup-2
Figures
Fig. 1. View of the asymmetric unit of the compound showing the atom-labelling scheme.
Displacement ellipsoids are drawn at the 30% probability level. H atoms are presented as a
small spheres of arbitrary radius.




C11H11NO4S·H2O F(000) = 568
Mr = 271.28 Dx = 1.423 Mg m−3
Monoclinic, P21/n Mo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2yn Cell parameters from 889 reflections
a = 10.684 (4) Å θ = 2.8–27.5°
b = 8.151 (3) Å µ = 0.27 mm−1
c = 14.747 (5) Å T = 293 K
β = 99.657 (4)° Block, yellow
V = 1266.0 (8) Å3 0.15 × 0.12 × 0.10 mm
Z = 4
Data collection
Bruker SMART 1000 CCD area-detector
diffractometer 2226 independent reflections
Radiation source: fine-focus sealed tube 1902 reflections with I > 2σ(I)
graphite Rint = 0.047
Detector resolution: 10.0 pixels mm-1 θmax = 25.0°, θmin = 2.2°




Tmin = 0.960, Tmax = 0.974 l = −16→17
4985 measured reflections
Refinement
Refinement on F2 Primary atom site location: structure-invariant direct
methods
Least-squares matrix: full Secondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.043








2) + (0.0681P)2 + 0.2943P]
where P = (Fo
2 + 2Fc
2)/3
2226 reflections (Δ/σ)max = 0.001
171 parameters Δρmax = 0.22 e Å−3
0 restraints Δρmin = −0.31 e Å−3
Special details
Experimental. 1H NMR (300 MHz, CDCl3): δ 8.72(bar, 1H, N—H), 6.87–6.71 (m, 3H, 8-H, 11-H, 12-H), 5.46 (bar, 1H, 10-OH),
4.47–4.51 (m, 1H, 5-H), 3.83 (s, 3H, 9-OCH3), 3.46 (dd, 1H, j=14.4, 4.2, 3-H), 3.06 (dd, 1H, j=14.1, 9.6, 3-H). 13C NMR (300 MHz,
CDCl3): δ 174.5, 167.5, 147.8, 145.7, 132.7, 123.1, 116.7, 114.9, 57.2, 56.1, 36.2. MS(ESI) m/z calc. for C11H11NO4S 253.27, found
[M–1]+ 252.15. m.p. 109-110°C
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance mat-
rix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations
between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of
cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
S1 0.49420 (5) 1.06186 (7) 0.70922 (3) 0.0523 (2)
N3 0.51317 (16) 1.07172 (19) 0.88568 (11) 0.0430 (4)
H3 0.5303 1.1072 0.9413 0.052*
C2 0.5427 (2) 1.1623 (3) 0.81421 (15) 0.0529 (5)
C4 0.45618 (17) 0.9243 (2) 0.86643 (12) 0.0383 (4)
C5 0.43481 (18) 0.8857 (2) 0.76418 (12) 0.0403 (4)
H5 0.4868 0.7902 0.7545 0.048*
C6 0.29661 (18) 0.8453 (3) 0.72695 (13) 0.0448 (5)
H6A 0.2706 0.7526 0.7606 0.054*
H6B 0.2440 0.9383 0.7370 0.054*
C7 0.27553 (18) 0.8048 (2) 0.62553 (13) 0.0407 (4)
C8 0.31489 (17) 0.6537 (2) 0.59516 (12) 0.0386 (4)
H8 0.3523 0.5768 0.6378 0.046*
C9 0.29866 (16) 0.6178 (2) 0.50237 (12) 0.0360 (4)
C10 0.24649 (18) 0.7353 (2) 0.43822 (12) 0.0408 (4)
C11 0.2075 (2) 0.8830 (2) 0.46857 (14) 0.0512 (5)
H11 0.1718 0.9613 0.4261 0.061*
C12 0.2206 (2) 0.9167 (2) 0.56175 (14) 0.0504 (5)
H12 0.1918 1.0163 0.5812 0.061*
C13 0.3765 (2) 0.3430 (3) 0.52648 (16) 0.0541 (5)
H13A 0.3955 0.2494 0.4917 0.081*supplementary materials
sup-4
H13B 0.3128 0.3141 0.5625 0.081*
H13C 0.4520 0.3781 0.5665 0.081*
O1 0.5944 (2) 1.2929 (2) 0.82373 (12) 0.0877 (7)
O2 0.42480 (14) 0.83322 (17) 0.92352 (9) 0.0483 (4)
O3 0.33054 (14) 0.47280 (16) 0.46520 (9) 0.0485 (4)
O4 0.23570 (15) 0.69314 (17) 0.34819 (9) 0.0537 (4)
H4A 0.2034 0.7691 0.3160 0.080*
O5 0.36833 (18) 0.4211 (2) 0.27286 (12) 0.0558 (4)
H5A 0.336 (4) 0.444 (5) 0.318 (3) 0.134 (16)*
H5B 0.376 (3) 0.518 (4) 0.253 (2) 0.085 (10)*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
S1 0.0699 (4) 0.0527 (4) 0.0342 (3) −0.0171 (2) 0.0079 (2) 0.0023 (2)
N3 0.0578 (10) 0.0384 (9) 0.0326 (8) −0.0079 (7) 0.0065 (7) −0.0046 (6)
C2 0.0715 (14) 0.0423 (11) 0.0453 (11) −0.0124 (10) 0.0112 (10) −0.0012 (9)
C4 0.0432 (9) 0.0353 (10) 0.0352 (9) −0.0008 (7) 0.0033 (7) −0.0011 (7)
C5 0.0510 (10) 0.0365 (10) 0.0332 (9) −0.0018 (8) 0.0060 (8) −0.0021 (8)
C6 0.0518 (11) 0.0454 (11) 0.0374 (10) −0.0063 (9) 0.0079 (8) −0.0067 (8)
C7 0.0465 (10) 0.0381 (10) 0.0369 (10) −0.0074 (8) 0.0050 (8) −0.0055 (8)
C8 0.0441 (9) 0.0368 (10) 0.0337 (9) −0.0031 (8) 0.0029 (7) 0.0046 (7)
C9 0.0409 (9) 0.0300 (9) 0.0367 (9) −0.0029 (7) 0.0051 (7) −0.0018 (7)
C10 0.0509 (10) 0.0363 (10) 0.0328 (9) −0.0020 (8) 0.0006 (8) −0.0018 (7)
C11 0.0727 (14) 0.0357 (10) 0.0405 (10) 0.0059 (10) −0.0042 (9) 0.0021 (8)
C12 0.0679 (13) 0.0344 (10) 0.0466 (11) 0.0016 (9) 0.0028 (10) −0.0078 (8)
C13 0.0650 (13) 0.0390 (11) 0.0599 (13) 0.0097 (10) 0.0149 (10) 0.0102 (10)
O1 0.1467 (19) 0.0578 (11) 0.0617 (11) −0.0545 (12) 0.0262 (11) −0.0083 (8)
O2 0.0667 (9) 0.0429 (7) 0.0340 (7) −0.0108 (7) 0.0047 (6) 0.0033 (6)
O3 0.0718 (9) 0.0344 (7) 0.0391 (7) 0.0089 (7) 0.0084 (6) 0.0019 (6)
O4 0.0836 (10) 0.0421 (8) 0.0312 (7) 0.0092 (7) −0.0022 (7) −0.0009 (6)
O5 0.0797 (11) 0.0438 (9) 0.0440 (8) 0.0040 (8) 0.0106 (8) −0.0066 (7)
Geometric parameters (Å, °)
S1—C2 1.751 (2) C8—H8 0.9300
S1—C5 1.815 (2) C9—O3 1.370 (2)
N3—C4 1.356 (2) C9—C10 1.395 (3)
N3—C2 1.366 (3) C10—O4 1.358 (2)
N3—H3 0.8600 C10—C11 1.373 (3)
C2—O1 1.197 (3) C11—C12 1.385 (3)
C4—O2 1.211 (2) C11—H11 0.9300
C4—C5 1.520 (2) C12—H12 0.9300
C5—C6 1.523 (3) C13—O3 1.424 (2)
C5—H5 0.9800 C13—H13A 0.9600
C6—C7 1.511 (3) C13—H13B 0.9600
C6—H6A 0.9700 C13—H13C 0.9600
C6—H6B 0.9700 O4—H4A 0.8200
C7—C12 1.370 (3) O5—H5A 0.82 (5)supplementary materials
sup-5
C7—C8 1.399 (3) O5—H5B 0.85 (3)
C8—C9 1.382 (3)
C2—S1—C5 92.79 (9) C9—C8—C7 120.60 (17)
C4—N3—C2 118.11 (16) C9—C8—H8 119.7
C4—N3—H3 120.9 C7—C8—H8 119.7
C2—N3—H3 120.9 O3—C9—C8 125.52 (16)
O1—C2—N3 123.5 (2) O3—C9—C10 114.77 (15)
O1—C2—S1 125.58 (18) C8—C9—C10 119.71 (17)
N3—C2—S1 110.93 (15) O4—C10—C11 124.07 (17)
O2—C4—N3 124.38 (17) O4—C10—C9 116.61 (16)
O2—C4—C5 123.37 (17) C11—C10—C9 119.31 (17)
N3—C4—C5 112.25 (16) C10—C11—C12 120.76 (18)
C4—C5—C6 112.19 (15) C10—C11—H11 119.6
C4—C5—S1 105.90 (13) C12—C11—H11 119.6
C6—C5—S1 113.61 (13) C7—C12—C11 120.64 (19)
C4—C5—H5 108.3 C7—C12—H12 119.7
C6—C5—H5 108.3 C11—C12—H12 119.7
S1—C5—H5 108.3 O3—C13—H13A 109.5
C7—C6—C5 112.25 (15) O3—C13—H13B 109.5
C7—C6—H6A 109.2 H13A—C13—H13B 109.5
C5—C6—H6A 109.2 O3—C13—H13C 109.5
C7—C6—H6B 109.2 H13A—C13—H13C 109.5
C5—C6—H6B 109.2 H13B—C13—H13C 109.5
H6A—C6—H6B 107.9 C9—O3—C13 118.00 (15)
C12—C7—C8 118.92 (18) C10—O4—H4A 109.5
C12—C7—C6 120.66 (18) H5A—O5—H5B 98 (3)
C8—C7—C6 120.40 (17)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
N3—H3···O2i 0.86 2.03 2.886 (2) 174
O4—H4A···O5ii 0.82 1.87 2.685 (2) 171
O5—H5A···O3 0.82 (5) 2.19 (5) 2.962 (2) 156 (4)
O5—H5A···O4 0.82 (5) 2.37 (4) 2.947 (2) 127 (4)
O5—H5B···O1iii 0.85 (3) 1.97 (3) 2.795 (3) 163 (3)
Symmetry codes: (i) −x+1, −y+2, −z+2; (ii) −x+1/2, y+1/2, −z+1/2; (iii) −x+1, −y+2, −z+1.supplementary materials
sup-6
Fig. 1supplementary materials
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Fig. 2